Adrian Newman-Tancredi

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

Journal of psychopharmacology (Oxford, England)

ACS chemical neuroscience

Journal of medicinal chemistry

The Journal of pharmacy and pharmacology

Neurolixis

University of Kent (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Neurolixis

France

Chief Executive Officer

NeuroAct

France

Neuropharmacology Consultant

Neurolixis

France

Chief Scientific Officer

Centre de Recherche Pierre Fabre

France

Director :: Neurobiology

Institut de Recherches Servier

France

Senior Scientist :: Psychopharmacology

Education History

University of Kent

United Kingdom

PHD :: Biological Laboratory

University of Kent

United Kingdom

BSC :: Biological Laboratory

Publications

Mariusz Papp, Piotr Gruca, Ewa Litwa, Magdalena Lason, Adrian Newman-Tancredi, Ronan Depoortère
The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Mariusz Papp, Piotr Gruca, Ewa Litwa, Magdalena Lason, Adrian Newman-Tancredi, Ronan Depoortère
The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms. Journal of psychopharmacology (Oxford, England) (2024)
Mariusz Papp, Piotr Gruca, Ewa Litwa, Magdalena Lason, Adrian Newman-Tancredi, Ronan Depoortère
The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms. Journal of psychopharmacology (Oxford, England) (2024)
Arnauld Belmer, Ronan Depoortere, Kate Beecher, Adrian Newman-Tancredi, Selena E Bartlett
Neural serotonergic circuits for controlling long-term voluntary alcohol consumption in mice. Molecular psychiatry (2022)
Sharon Cabanu, Fuencisla Pilar-Cuéllar, Paula Zubakina, Eva Florensa-Zanuy, Júlia Senserrich, Adrian Newman-Tancredi, Albert Adell
Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT 1A Receptor Biased Agonist. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Mariusz Papp, Wiesław Jerzy Cubała, Lukasz Swiecicki, Adrian Newman-Tancredi, Paul Willner
Perspectives for therapy of treatment-resistant depression. British journal of pharmacology (2021)
Joanna Sniecikowska, Monika Gluch-Lutwin, Adam Bucki, Anna Więckowska, Agata Siwek, Magdalena Jastrzebska-Wiesek, Anna Partyka, Daria Wilczyńska, Karolina Pytka, Gniewomir Latacz, Katarzyna Przejczowska-Pomierny, Elżbieta Wyska, Anna Wesołowska, Maciej Pawłowski, Adrian Newman-Tancredi, Marcin Kolaczkowski
Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT1A Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile. Journal of medicinal chemistry 63 (19) (2020)
Ronan Depoortère, Laurent Bardin, Mark A Varney, Adrian Newman-Tancredi
Serotonin 5-HT1A Receptor Biased Agonists Display Differential Anxiolytic Activity in a Rat Social Interaction Model. ACS chemical neuroscience 10 (7) (2019)
Joanna Sniecikowska, Monika Gluch-Lutwin, Adam Bucki, Anna Więckowska, Agata Siwek, Magdalena Jastrzebska-Wiesek, Anna Partyka, Daria Wilczyńska, Karolina Pytka, Krzysztof Pociecha, Agnieszka Cios, Elżbieta Wyska, Anna Wesołowska, Maciej Pawłowski, Mark A Varney, Adrian Newman-Tancredi, Marcin Kolaczkowski
Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT1A Receptor-Biased Agonists with Robust Antidepressant-like Activity. Journal of medicinal chemistry 62 (5) (2019)
Elise Levigoureux, Benjamin Vidal, Sylvain Fieux, Caroline Bouillot, Stéphane Emery, Adrian Newman-Tancredi, Luc Zimmer
Serotonin 5-HT1A Receptor Biased Agonists Induce Different Cerebral Metabolic Responses: A [18F]-Fluorodesoxyglucose Positron Emission Tomography Study in Conscious and Anesthetized Rats. ACS chemical neuroscience 10 (7) (2019)
Adrian Newman-Tancredi, Mark A Varney, Andrew C McCreary
Effects of the Serotonin 5-HT1A Receptor Biased Agonists, F13714 and F15599, on Striatal Neurotransmitter Levels Following L-DOPA Administration in Hemi-Parkinsonian Rats. Neurochemical research 43 (5) (2018)
Magdalena Jastrzębska-Więsek, Anna Partyka, Joanna Rychtyk, Joanna Śniecikowska, Marcin Kołaczkowski, Anna Wesołowska, Mark A Varney, Adrian Newman-Tancredi
Activity of Serotonin 5-HT1A Receptor Biased Agonists in Rat: Anxiolytic and Antidepressant-like properties. ACS chemical neuroscience 9 (5) (2018)
Adrian Newman-Tancredi, Jean-Claude Martel, Cristina Cosi, Peter Heusler, Fabrice Lestienne, Mark A Varney, Didier Cussac
Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT1A receptor agonist. The Journal of pharmacy and pharmacology 69 (9) (2017)

Adrian Newman-Tancredi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Adrian Newman-Tancredi